{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:41:23Z","timestamp":1789195283476,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.breast.2014.12.003","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T17:15:15Z","timestamp":1420046115000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical relevance of normal and tumour cell radiosensitivity in BRCA1\/BRCA2 mutation carriers: A review"],"prefix":"10.1016","volume":"24","author":[{"given":"Jacques","family":"Bernier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2014.12.003_bib1","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.breast.2014.12.003_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A\u00a0strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.breast.2014.12.003_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.breast.2014.12.003_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/jnci\/85.11.892","article-title":"The lifetime risk of developing breast cancer","volume":"85","author":"Feuer","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2014.12.003_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.breast.2014.12.003_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.2007.55-a","article-title":"Variation of breast cancer risk among BRCA1\/2 carriers","volume":"299","author":"Begg","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2014.12.003_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semradonc.2010.08.008","article-title":"Radiotherapy in the hereditary breast cancer","volume":"21","author":"Pierce","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib9","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2014.12.003_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/386804a0","article-title":"Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2","volume":"386","author":"Sharan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.breast.2014.12.003_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1088\/0031-9155\/41\/2\/001","article-title":"From targets to genes: a brief history of radiosensitivity","volume":"41","author":"Steel","year":"1996","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib13","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib14","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1128\/MCB.23.16.5706-5715.2003","article-title":"Pathways of DNA double-strand break repair during the mammalian cell cycle","volume":"23","author":"Rothkamm","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","article-title":"Association of BRCA1 with RAD51 in mitotic and meiotic cells","volume":"88","author":"Scully","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.breast.2014.12.003_bib16","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1093\/nar\/gkh703","article-title":"Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells","volume":"32","author":"Saleh-Gohari","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.breast.2014.12.003_bib17","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2014.12.003_bib18","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/1078-0432.CCR-11-3150","article-title":"Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement","volume":"18","author":"Lok","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib19","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/MCB.21.10.3445-3450.2001","article-title":"Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation","volume":"21","author":"Xu","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1097-2765(01)00174-5","article-title":"BRCA2 is required for homology-directed repair of chromosomal breaks","volume":"7","author":"Moynahan","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.breast.2014.12.003_bib21","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1038\/sj.onc.1203334","article-title":"BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene","volume":"8","author":"Snouwaert","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2014.12.003_bib22","doi-asserted-by":"crossref","first-page":"32931","DOI":"10.1074\/jbc.274.46.32931","article-title":"Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)\/M checkpoint control","volume":"12","author":"Chen","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.breast.2014.12.003_bib23","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.dnarep.2008.08.001","article-title":"Mitotic delay in lymphocytes from BRCA1 heterozygotes unable to reduce the radiation-induced chromosomal damage","volume":"7","author":"Febrer","year":"2008","journal-title":"DNA Repair"},{"key":"10.1016\/j.breast.2014.12.003_bib24","first-page":"5548","article-title":"BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells","volume":"60","author":"Le Page","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib25","doi-asserted-by":"crossref","first-page":"19092","DOI":"10.1074\/jbc.M110.104430","article-title":"Transcriptional regulation of the base excision repair pathway by BRCA1","volume":"285","author":"Saha","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.breast.2014.12.003_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80769-2","article-title":"Induction of GADD45 and JNK\/SAPK-dependent apoptosis following inducible expression of BRCA1","volume":"97","author":"Harkin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.breast.2014.12.003_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2008.01.001","article-title":"BARD1 regulates BRCA1-mediated transactivation of the p21WAF1\/CIP1 and Gadd45 promoters","volume":"263","author":"Fabbro","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.breast.2014.12.003_bib28","first-page":"270","article-title":"Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumour cells deficient in BRCA1 or BRCA2","volume":"61","author":"Wang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib29","first-page":"1245","article-title":"DNA-dependent protein kinase stimulates an independently active, non-homologous, end-joining apparatus","volume":"60","author":"DiBiase","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijrobp.2009.10.020","article-title":"Increased chromosomal radiosensitivity in women carrying BRCA1\/BRCA2 mutations assessed with the G2 assay","volume":"76","author":"Ernestos","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2014.12.003_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ijc.10109","article-title":"Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 and BRCA2","volume":"97","author":"Buchholz","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.bjc.6602912","article-title":"Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers","volume":"94","author":"Kote-Jarai","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/ijc.22915","article-title":"Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility","volume":"121","author":"Barwell","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09553000110097974","article-title":"BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage","volume":"78","author":"Nieuwenhuis","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/09553000400017937","article-title":"Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers","volume":"80","author":"Baeyens","year":"2004","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2006.01.006","article-title":"Histopathology of BRCA1- and BRCA2-associated breast cancer","volume":"59","author":"Honrado","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.breast.2014.12.003_bib37","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","article-title":"Effect\u00a0of radiotherapy following breast-conserving treatment in women with\u00a0breast cancer and germline BRCA1\/2 mutations","volume":"18","author":"Pierce","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib38","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1158\/1078-0432.CCR-06-1246","article-title":"Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom","volume":"12","author":"Shanley","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09553002.2013.835504","article-title":"Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations","volume":"90","author":"Park","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.breast.2014.12.003_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Conservatively managed early onset breast cancer: outcome as a function of germline BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2014.12.003_bib41","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","article-title":"Ten year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage. I\/II breast cancer","volume":"24","author":"Pierce","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib42","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1245\/s10434-009-0638-7","article-title":"Breast conserving surgery in BRCA1\/2 mutation carriers: are we approaching an answer?","volume":"16","author":"Garcia-Etienne","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-009-0685-6","article-title":"Is the breast-conserving treatment with radiotherapy appropriate in BRCA1\/2 mutation carriers? Long-term results and review of the literature","volume":"120","author":"Kirova","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2014.12.003_bib44","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","article-title":"Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations","volume":"91","author":"Robson","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2014.12.003_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-010-0894-z","article-title":"Local therapy in BRCA1\/2 carriers with operable breast cancer: comparison of breast conservation and mastectomy","volume":"121","author":"Pierce","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2014.12.003_bib46","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib47","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1200\/JCO.2007.16.0192","article-title":"Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer","volume":"26","author":"Hooning","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib48","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ejca.2013.04.028","article-title":"Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE Study Report","volume":"49","author":"Bernstein","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib49","doi-asserted-by":"crossref","first-page":"481563","DOI":"10.4061\/2011\/481563","article-title":"Prophylactic and therapeutic breast conservation in BRCA1\/2 mutation carriers","volume":"2011","author":"Croshaw","year":"2011","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib50","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr658","article-title":"A\u00a0combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment","volume":"6","author":"Robson","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2014.12.003_bib51","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","article-title":"Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases","volume":"43","author":"Brekelmans","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.breast.2014.12.003_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.20728","article-title":"Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series","volume":"103","author":"Robson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1245\/ASO.2004.05.018","article-title":"Survival and recurrence after breast cancer in BRCA1\/2 mutation carriers","volume":"11","author":"El-Tamer","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa070608","article-title":"Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations","volume":"357","author":"Rennert","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2014.12.003_bib56","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1200\/JCO.1999.17.10.3017","article-title":"BRCA1\/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast conserving management in patients with BRCA1\/BRCA2 mutations","volume":"17","author":"Turner","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(98)00023-1","article-title":"Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations","volume":"47","author":"Gaffney","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/COC.0b013e31817f9e1c","article-title":"Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1\/2 mutations status","volume":"32","author":"Fourquet","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.003_bib59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10549-014-3115-3","article-title":"High risk of in-breast tumor recurrence after BRCA1\/2-associated breast cancer","volume":"147","author":"Nilsson","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2014.12.003_bib60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ejca.2004.01.017","article-title":"Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy","volume":"40","author":"Seynaeve","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2014.12.003_bib61","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2005.02.037","article-title":"Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy","volume":"41","author":"Kirova","year":"2005","journal-title":"Eur J Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977614002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977614002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:32:17Z","timestamp":1760776337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977614002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0960977614002227"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2014.12.003","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical relevance of normal and tumour cell radiosensitivity in BRCA1\/BRCA2 mutation carriers: A review","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2014.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}